SFX by Ex Libris Inc.

Title:	Immunotherapeutic approaches to Alzheimer's disease
Source:	Science [0036-8075] Monsonego, A yr:2003

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Roberson, Lennart D. "100 Years and Counting: Prospects for Defeating Alzheimer's Disease." Science 314.5800 (2006): 781-784.
description	2.	Gelinas, Daniela S. "Immunotherapy for Alzheimer's disease." Proceedings of the National Academy of Sciences of the United States of America 101.SUPPL. 2 (2004): 14657-62.
description	3.	Nicoll, James A R A. "Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial." Lancet, The 372.9634 (2008): 216-23.
description	4.	Schwartz, M. "Microglial phenotype: is the commitment reversible?" Trends in Neurosciences 29.2 (2006): 68-74.
description	5.	Ozdinler, Jeffrey H. "IGF-I specifically enhances axon outgrowth of corticospinal motor neurons." Nature neuroscience 9.11 (2006): 1371-1381.
description	6.	Selkoe, D J J. "Alzheimer's disease: genes, proteins, and therapy." Physiological reviews 81.2 (2001): 741-66.
description	7.	Goedert, M. "A Century of Alzheimer's Disease." Science 314.5800 (2006): 777-81.
description	8.	"Alzheimer Dementia." American Physiological Society. 741-766.
description	9.	Hardy, J. "A hundred years of Alzheimer's disease research." Neuron 52.1 (2006): 3-13.
description	10.	Markham, P. "Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report." Nature medicine 9.4 (2003): 448-52.
description	11.	Little, Deborah M. "Semantic encoding of spoken sentences: Adult aging and the preservation of conceptual short-term memory." Applied psycholinguistics 27.3 (2006): 487-511.
description	12.	Blennow, K. "Alzheimer's disease." The lancet 368.9533 (2006): 387-403.
description	13.	Aisen, D. "Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study." Lancet, The 372.9634 (2008): 207-15.
description	14.	Butovsky, O. "Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem progenitor cells." Molecular and cellular neurosciences 31.1 (2005): 149-60.
description	15.	Ballenger, Jesse F. F. Bulletin of the history of medicine 78.3: 728-730.
description	16.	Shivraj Sohur, U. "Adult neurogenesis and cellular brain repair with neural progenitors, precursors and stem cells." Philosophical transactions of the Royal Society of London. Series B, Biological sciences 361.1473 (2006): 1477-1497.
description	17.	Molyneaux, Bradley J J. "Fezl is required for the birth and specification of corticospinal motor neurons." Neuron 47.6: 817-831.
description	18.	Vlad, Steven C C. "Protective effects of NSAIDs on the development of Alzheimer disease." Neurology 70.19 (2008): 1672-1677.
description	19.	Kayed, R. "Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis." Science 300.5618 (2003): 486-489.
description	20.	Meyer-Luehmann, M. "Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease." Nature 451.7179 (2008): 720-4.